Brandon, Canada Clinical Trials

A listing of Brandon, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 8 clinical trials
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

This is a Phase 3, randomized, double-blind, placebo-controlled study to explore the effect of oral ozanimod as an induction treatment for subjects with moderately to severely active Crohn's Disease.

ileal disease
immunomodulators
abdominal pain
crohn's disease
endoscopy
Brandon Medical Arts Clinic
 (0.3 away) Contact site
  • 397 views
  • 12 Mar, 2021
  • +387 other locations
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

This is a Phase 3, open-label, multicenter extension study to evaluate safety and efficacy of ozanimod in subjects with moderately to severely active Crohn's Disease.

remission
crohn's disease
Brandon Medical Arts Clinic
 (0.3 away) Contact site
  • 1035 views
  • 22 Feb, 2021
  • +807 other locations
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

This is a Phase 3, randomized, double-blind, placebo-controlled study to demonstrate the effect of oral ozanimod as maintenance therapy in subjects with moderately to severely active Crohn's Disease.

remission
abdominal pain
crohn's disease
Brandon Medical Arts Clinic
 (0.3 away) Contact site
  • 858 views
  • 23 Feb, 2021
  • +780 other locations
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

The purpose of this study is to evaluate the safety and efficacy of Mirikizumab in participants with moderately to severely active ulcerative colitis (UC) who have had an inadequate response to, loss of response, or intolerant to conventional or biologic therapy for UC.

mirikizumab
Brandon Medical Arts Clinic
 (0.3 away) Contact site
  • 1722 views
  • 24 Jul, 2021
  • +880 other locations
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

The purpose of this study is to evaluate the efficacy and safety of mirikizumab as maintenance therapy in participants who completed prior 12-week induction study AMAN (NCT03518086).

endoscopy
mirikizumab
Brandon Medical Arts Clinic
 (0.3 away) Contact site
  • 386 views
  • 26 Jul, 2021
  • +906 other locations
Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate

The purpose of this study is to determine the effectiveness of darolutamide as part of adjuvant androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate cancer at very high risk of recurrence.

adenocarcinoma
external beam radiation therapy
neutrophil count
extracapsular extension
prostatectomy
Western Manitoba Cancer Centre - Prairie Mountain Health
 (0.9 away) Contact site
  • 62 views
  • 28 Jul, 2021
  • +47 other locations
Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate

In current clinical practice, an acceptable standard treatment for locally advanced prostate cancer is radiation therapy in combination with hormone therapy (called Treatment B or Group B in this study). However, despite our best treatments, there is a risk that the prostate cancer may eventually return. As well, the hormonal …

adenocarcinoma
external beam radiation therapy
hormone therapy
antiandrogen therapy
diabetes
Prairie Mountain Health - Western Manitoba Cancer Centre
 (0.9 away) Contact site
  • 47 views
  • 22 Jan, 2021
  • +2 other locations
Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis

This study will assess the use of risankizumab in adult patients with moderate to severe chronic plaque psoriasis and compare risankizumab to other commonly used biologics.

Jason Ronald Sneath Medical Co /ID# 213082
 (0.1 away) Contact site
  • 93 views
  • 28 Jun, 2021
  • +344 other locations